Dimensional Fund Advisors
ORIC icon

Dimensional Fund Advisors’s Oric Pharmaceuticals ORIC Stock Holding History

Dimensional Fund Advisors’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.5M Buy
1,801,399
+330,109
+22% +$2.99M ﹤0.01% 2049
2026
Q1 		$18.6M Buy
1,471,290
+244,060
+20% +$2.77M ﹤0.01% 2008
2025
Q4 		$10M Buy
1,227,230
+433,359
+55% +$4.99M ﹤0.01% 2282
2025
Q3 		$9.52M Buy
793,871
+79,005
+11% +$831K ﹤0.01% 2320
2025
Q2 		$7.26M Sell
714,866
-12,964
-2% -$87K ﹤0.01% 2407
2025
Q1 		$4.06M Buy
727,830
+10,642
+1% +$93.1K ﹤0.01% 2555
2024
Q4 		$5.79M Buy
717,188
+103,237
+17% +$947K ﹤0.01% 2494
2024
Q3 		$6.29M Buy
613,951
+147,289
+32% +$1.46M ﹤0.01% 2454
2024
Q2 		$3.3M Buy
466,662
+305,860
+190% +$2.74M ﹤0.01% 2620
2024
Q1 		$2.21M Buy
160,802
+136,126
+552% +$1.62M ﹤0.01% 2771
2023
Q4 		$227K Sell
24,676
-16
-0.1% -$116 ﹤0.01% 3178
2023
Q3 		$149K Buy
24,692
+16
+0.1% +$131 ﹤0.01% 3259
2023
Q2 		$191K Buy
24,676
+14,632
+146% +$83.1K ﹤0.01% 3243
2023
Q1 		$57.3K Buy
+10,044
New +$52.5K ﹤0.01% 3372

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors's ORIC Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Oric Pharmaceuticals (ORIC) stake by 22% in Q2 2026, buying an estimated $2.99M and bringing the position to 1,801,399 shares worth $19.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2049.

Dimensional Fund Advisors first reported a position in ORIC in Q1 2023 and has held it in 14 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Dimensional Fund Advisors held 1,801,399 shares of Oric Pharmaceuticals worth $19.5M as of Q2 2026.
  • Dimensional Fund Advisors bought 330,109 Oric Pharmaceuticals shares in Q2 2026, an estimated $2.99M.
  • Oric Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2049 holding.
  • Dimensional Fund Advisors first reported a position in Oric Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.